An open science pathway for drug marketing authorization—Registered drug approval

Florian Naudet, Maximilian Siebert, Rémy Boussageon, Ioana A Cristea and Erick H Turner

PLOS Medicine, 2021, vol. 18, issue 8, 1-5

Abstract: Florian Naudet and co-authors propose a pathway involving registered criteria for evaluation and approval of new drugs.

Date: 2021
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1003726 (text/html)
https://journals.plos.org/plosmedicine/article/fil ... 03726&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pmed00:1003726

DOI: 10.1371/journal.pmed.1003726

Access Statistics for this article

More articles in PLOS Medicine from Public Library of Science
Bibliographic data for series maintained by plosmedicine ().